PIRA or Progression Independent of Relapse Activity is a term you would come across MS literature increasingly over the past few years. This was a concept or term coined to understand and explain disability worsening in a patient with multiple sclerosis without that patient having had relapses. If an MS patient’s baseline disability got worse because they had a severe relapse from which they did not fully recover and now they have a permanent residual deficit, its called RAW or Relapse Associated Worsening. On the other hand, if a patient did not have any relapses, but over time their baseline function declined due to MS, that is due to PIRA or Progression Independent of Relapse Activity.
As our current treatments have gotten better and better at preventing relapses, we have made significant strides in decreasing the rates of RAW ( Relapse Associated Worsening).
In MS research, the focus has now shifted more towards understanding and preventing PIRA (Progression Independent of Relapse Activity).
As we try to understand disease progression, the need to better define it becomes apparent. A newer term called PIRMA (Progression Independent of Relapse and MRI Activity) has also been introduced as well. Since relapses and new lesions are associated with bouts of inflammation seen in relapsing disease, PIRMA (Progression Independent of Relapse and MRI Activity) helps to further delineate progression without any kind of clinical (relapses) or MRI activity.
Studying PIRA/PIRMA will help us understand the mechanisms causing progressive MS and are especially helpful in evaluating for efficacy of medications in preventing/reversing disability in purely progressive forms of multiple sclerosis.
